Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)

ClinicalTrials.gov ID: NCT02718417

Public ClinicalTrials.gov record NCT02718417. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 11:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AND/OR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCER JAVELIN OVARIAN 100

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, open-label, international, multi-center, efficacy, and safety study of avelumab in combination with and/or following platinum-based chemotherapy. Eligible patients must have previously untreated, histologically confirmed Stage III-IV epithelial ovarian (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer (PPC) and be candidates for platinum-based chemotherapy. The primary purpose of the study is to demonstrate if avelumab given as single agent in the maintenance setting following frontline chemotherapy or in combination with carboplatin/paclitaxel is superior to platinum-based chemotherapy alone followed by observation in this population of newly diagnosed ovarian cancer patients.

Study identification

NCT ID
NCT02718417
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
998 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 19, 2016 (Actual)
Primary completion
Sep 7, 2018 (Actual)
Completion
May 16, 2019 (Actual)
Last update posted
Jul 14, 2020

2016 – 2019

United States locations

U.S. sites
146
U.S. states
22
U.S. cities
73
Facility City State ZIP Site status
Alabama Oncology Alabaster Alabama 35007 —
Alabama Oncology Bessemer Alabama 35022 —
Alabama Oncology, Bruno Cancer Center Birmingham Alabama 35205 —
Alabama Oncology Birmingham Alabama 35209 —
Alabama Oncology Birmingham Alabama 35211 —
Alabama Oncology Birmingham Alabama 35235 —
Alabama Oncology Birmingham Alabama 35243 —
Arizona Oncology Associates, PC - HAL Phoenix Arizona 85016 —
Arizona Oncology Associates, PC - HAL Phoenix Arizona 85027 —
Arizona Oncology Associates, PC - HAL Scottsdale Arizona 85258 —
Arizona Oncology Associates, PC - HAL Tempe Arizona 85284 —
Arizona Oncology Associates, PC-HOPE Tucson Arizona 85704 —
Arizona Oncology Associates, PC-HOPE Tucson Arizona 85711 —
Highlands Oncology Group Fayetteville Arkansas 72703 —
Highlands Oncology Group Rogers Arkansas 72758 —
Oso HomeCare Irvine California 92614 —
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048 —
Medical Center, Cedars-Sinai Los Angeles California 90048 —
Gynecologic Oncology Associates Newport Beach California 92663 —
Chao Family Comprehensive Cancer Center Orange California 92868 —
Hematology-Oncology Medical Group of Orange County Orange California 92868 —
Medical Oncology Care Associates Orange California 92868 —
St. Joseph Hospital of Orange Orange California 92868 —
The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange Orange California 92868 —
UC Irvine Health Orange California 92868 —
University of California, Irvine/UC Irvine Health Orange California 92868 —
California Pacific Medical Center - Medical Office Building San Francisco California 94109 —
California Pacific Medical Center - Van Ness Campus San Francisco California 94109 —
California Pacific Medical Center - Davies Campus San Francisco California 94114 —
Bryan Hemming Cancer Care Center - California Pacific Medical Center San Francisco California 94115 —
California Pacific Medical Center - Pacific Heights Outpatient Pharmacy San Francisco California 94115 —
California Pacific Medical Center-Pacific Campus San Francisco California 94115 —
California Pacific Medical Center-Research Institute San Francisco California 94115 —
Palo Alto Medical Foundation Group San Francisco California 94118 —
Sansum Clinic Santa Barbara California 93105 —
Sansum Clinic Solvang California 93463 —
Rocky Mountain Cancer Centers Aurora Colorado 80012 —
Rocky Mountain Cancer Centers Boulder Colorado 80303 —
Rocky Mountain Cancer Centers Lakewood Colorado 80228 —
C/O Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06510 —
Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06510 —
Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06520 —
Johns Hopkins Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
UHEALTH Deerfield Beach Deerfield Beach Florida 33442 —
University of Miami Hospital and Clinics Miami Florida 33136 —
Orlando Health Gynecological Cancer Center Orlando Florida 32806 —
Orlando Health UF Health Cancer Center Orlando Florida 32806 —
Orlando Health, Inc. Orlando Florida 32806 —
Orlando Health, Inc Orlando Florida 32806 —
Emory University Hospital Midtown Atlanta Georgia 30308 —
Emory University Hospital Atlanta Georgia 30322 —
Investigational Drug Service, Emory University Clinic Atlanta Georgia 30322 —
The Emory Clinic Atlanta Georgia 30322 —
Winship Cancer Institute Atlanta Georgia 30322 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore Maryland 21287 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21287 —
Rcca Md Llc Bethesda Maryland 20817 —
Rcca Md Llc Germantown Maryland 20874 —
SKCCC at Johns Hopkins, Green Spring Station Lutherville Maryland 21093 —
Women's Health Specialists of Montgomery County Rockville Maryland 20852 —
Holy Cross Resource Center Silver Spring Maryland 20902 —
Maryland Oncology Hematology Silver Spring Maryland 20904 —
Holy Cross Hospital, Pharmacy Silver Spring Maryland 20910 —
Holy Cross Hospital Silver Spring Maryland 20910 —
Maryland Oncology Hematology Wheaton Maryland 20902 —
Massachusetts General Hospital Attn: Svetlana Rashkova, RPh Boston Massachusetts 02114 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center Attn: Nisha Sharma Boston Massachusetts 02215 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD Boston Massachusetts 02215 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
Mercy Ministry Office Chesterfield Missouri 63017 —
Mercy - Women's Oncology Springfield Missouri 65804 —
Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center Springfield Missouri 65804 —
Mercy Hospital Springfield Springfield Missouri 65804 —
Summit Medical Group Berkeley Heights New Jersey 07922 —
Summit Medical Group PA Florham Park New Jersey 07932 —
University Hospital, Investigational Drug Pharmacy Newark New Jersey 07103-6750 —
University Hospital Newark New Jersey 07103-6750 —
University Hospital, Ambulatory Care Center Newark New Jersey 07103 —
University Hospital, The Cancer Center Newark New Jersey 07103 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Medical Arts Radiology Huntington New York 11743 —
ProHealth Radiology Huntington New York 11743 —
NYU Winthrop Hospital, Clinical Trials Center Mineola New York 11501 —
NYU Winthrop Hospital, Gynecologic Oncology Mineola New York 11501 —
NYU Winthrop Hospital, Infusion Center Mineola New York 11501 —
NYU Winthrop Hospital, Research Pharmacy Mineola New York 11501 —
NYU Winthrop Radiology Mineola New York 11501 —
Montefiore - Einstein Center for Cancer Care The Bronx New York 10461 —
Montefiore Medical Center The Bronx New York 10461 —
Montefiore Medical Center, Centennial Women's Center The Bronx New York 10467 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45211 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45236 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45242 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45245 —
MetroHealth Medical Center Cleveland Ohio 44106 —
MetroHealth Medical Center Cleveland Ohio 44109 —
OSU Wexner Medical Center, Arthur G. James Cancer Hospital & Solove Research Institute Columbus Ohio 43210 —
OSU Wexner Medical Center, Investigational Drug Services Columbus Ohio 43210 —
OSU Wexner Medical Center, Stefanie Spielman Comprehensive Breast Center Columbus Ohio 43212 —
Oncology Hematology Care, Inc. Fairfield Ohio 45014 —
OSU Wexner Medical Center, Gynecologic Oncology at Mill Run Hilliard Ohio 43026 —
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401 —
Asante Three Rivers Medical Center Grants Pass Oregon 97527 —
Hematology Oncology Associates Grants Pass Oregon 97527 —
Asante Pharmacy Medford Oregon 97501 —
Asante Rogue Regional Medical Center Medford Oregon 97504 —
Hematology Oncology Associates Medford Oregon 97504 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Magee-Women's Hospital of UPMC Pittsburgh Pennsylvania 15213 —
University of Pittsburgh Cancer Institute Investigational Drug Service Pittsburgh Pennsylvania 15232 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 —
Avera Cancer Institute Sioux Falls South Dakota 57105 —
Tennessee Oncology, PLLC Dickson Tennessee 37055 —
Tennessee Oncology, PLLC Franklin Tennessee 37067 —
Tennessee Oncology, PLLC Gallatin Tennessee 37066 —
Tennessee Oncology, PLLC Hermitage Tennessee 37076 —
Tennessee Oncology, PLLC Lebanon Tennessee 37090 —
Tennessee Oncology, PLLC Murfreesboro Tennessee 37129 —
Tennessee Oncology, PLLC Nashville Tennessee 37203 —
The Sarah Cannon Research Institute Nashville Tennessee 37203 —
Tennessee Oncology, PLLC Nashville Tennessee 37205 —
Tennessee Oncology, PLLC Nashville Tennessee 37207 —
Tennessee Oncology, PLLC Nashville Tennessee 37211 —
Tennessee Oncology, PLLC Shelbyville Tennessee 37160 —
Tennessee Oncology, PLLC Smyrna Tennessee 37167 —
Texas Oncology-Austin Central Austin Texas 78731 —
Texas Oncology - South Austin Austin Texas 78745 —
Texas Oncology Bedford Bedford Texas 76022 —
Parkland Health and Hospital System Dallas Texas 75235 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
UT Southwestern Medical Center-Clements University Hospital Dallas Texas 75390 —
UT Southwestern Medical Center-Zale Lipshy University Hospital Dallas Texas 75390 —
Texas Oncology - Fort Worth Cancer Center Fort Worth Texas 76104 —
US Oncology Investigational Products Center (IPC) Irving Texas 75063 —
US Oncology Investigational Products Center Irving Texas 75063 —
Texas Oncology - San Antonio Medical Center San Antonio Texas 78240 —
Utah Cancer Specialists Layton Utah 84041 —
Utah Cancer Specialists Murray Utah 84157 —
Utah Cancer Specialists Salt Lake City Utah 84102 —
Utah Cancer Specialists Salt Lake City Utah 84106 —
Utah Cancer Specialists West Jordan Utah 84088 —
Emily Couric Cancer Center Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 173 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02718417, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2020 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02718417 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →